Thyrotropin receptor autoantibodies in Graves' disease

Trends in Endocrinology and Metabolism

Volumn 16, Issue 5, 2005, Pages 243-248

  Schott, Matthias ^a   Scherbaum, Werner A ^a   Morgenthaler, Nils G ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b BRAHMS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

BINDING SITE; BIOASSAY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MOLECULAR INTERACTION; OUTCOMES RESEARCH; PATHOGENICITY; PREDICTION; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STIMULATION; THYROTOXICOSIS;

AUTOANTIBODIES; GRAVES DISEASE; HUMANS; PREDICTIVE VALUE OF TESTS; RECEPTORS, THYROTROPIN; RECURRENCE; THYROTOXICOSIS;

EID: 20744459473     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2005.05.009     Document Type: Review

References (81)

1. B. Rapoport The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies Endocr. Rev. 19 1998 673 716
2. A.V. Kajava Modeling of the three-dimensional structure of proteins with the typical leucine-rich repeats Structure 3 1995 867 877
3. G. Kleinau Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signalling interface J. Biol. Chem. 279 2004 51590 51600
4. G. Smits Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity EMBO J. 22 2003 2692 2703
5. G. Vassart A molecular dissection of the glycoprotein hormone receptors Trends Biochem. Sci. 29 2004 119 126
6. H. Loosfelt Two-subunit structure of the human thyrotropin receptor Proc. Natl. Acad. Sci. U. S. A. 89 1992 3765 3769
7. D. Russo Role of amino acids 261-418 in proteolytic cleavage of the extracellular region of the human thyrotropin receptor Endocrinology 130 1992 2135 2138
8. J. Couet Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease J. Biol. Chem. 271 1996 4545 4552
9. G.D. Chazenbalk Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites Endocrinology 138 1997 2893 2899
10. J. Couet Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain Biochemistry 35 1996 14800 14805
11. K. Tanaka Subunit structure of thyrotropin receptors expressed on the cell surface J. Biol. Chem. 274 1999 33979 33984
12. D. Russo A new structural model for the thyrotropin (TSH) receptor, as determined by covalent cross-linking of TSH to the recombinant receptor in intact cells: evidence for a single polypeptide chain Mol. Endocrinol. 5 1991 1607 1612
13. G.D. Chazenbalk Is receptor cleavage into two subunits necessary for thyrotropin action? Biochem. Biophys. Res. Commun. 225 1996 479 484
14. G.D. Chazenbalk On the functional importance of thyrotropin receptor intramolecular cleavage Endocrinology 140 1999 4516 4520
15. C.R. Chen Targeted restoration of cleavage in a noncleaving thyrotropin receptor demonstrates that cleavage is insufficient to enhance ligand-independent activity Endocrinology 144 2003 1324 1330
16. J. Van Sande In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence Eur. J. Biochem. 229 1995 338 343
17. I. Ciullo Functional assessment of the thyrotropin receptor-β subunit Endocrinology 144 2003 3176 3181
18. G.D. Chazenbalk Does thyrotropin cleave its cognate receptor? Endocrinology 145 2004 4 10
19. G. Vassart, and S. Costagliola A physiological role for the posttranslational cleavage of the thyrotropin receptor? Endocrinology 145 2004 1 3
20. C.R. Chen The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim J. Clin. Invest. 111 2003 1897 1904
21. S. Costagliola Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor FEBS Lett. 436 1998 427 433
22. G.D. Chazenbalk Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor J. Clin. Invest. 110 2002 209 217
23. M. Zhang The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design Endocrinology 141 2000 3514 3517
24. V. Vlaeminck-Guillem Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist Mol. Endocrinol. 16 2002 736 746
25. M. Quellari Role of cleavage and shedding in human thyrotropin receptor function and trafficking Eur. J. Biochem. 270 2003 3486 3497
26. R. Latif Localization and regulation of thyrotropin receptors within lipid rafts Endocrinology 144 2003 4725 4728
27. M.J. Costa Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling Endocrinology 145 2004 1464 1472
28. J.M. McKenzie Delayed thyroid response to serum from thyrotoxic patients Endocrinology 62 1958 865 868
29. J.M. McKenzie Humoral factors in the pathogenesis of Graves' disease Physiol. Rev. 48 1968 252 310
30. L. Chiovato Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor J. Endocrinol. Invest. 17 1994 809 816
31. K. Tahara Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients Biochem. Biophys. Res. Commun. 179 1991 70 77
32. Y. Nagayama Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors J. Clin. Invest. 88 1991 336 340
33. Y. Nagayama, and B. Rapoport Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30 J. Clin. Endocrinol. Metab. 75 1992 1425 1430
34. L. Schwarz-Lauer Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor Thyroid 12 2002 115 120
35. J. Sanders The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor J. Clin. Endocrinol. Metab. 84 1999 3797 3802
36. N.G. Morgenthaler New assay systems for thyrotropin receptor antibodies Curr. Opin. Endocrinol. Diabetes 6 1999 251 260
37. N.G. Morgenthaler Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies J. Clin. Endocrinol. Metab. 81 1996 700 706
38. M. Atger Autoantibodies interacting with purified native thyrotropin receptor Eur. J. Biochem. 265 1999 1022 1031
39. S.M. McLachlan, and B. Rapoport Monoclonal, human autoantibodies to the TSH receptor - the Holy Grail and why are we looking for it? J. Clin. Endocrinol. Metab. 81 1996 3152 3154
40. S. Costagliola Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor J. Immunol. 160 1998 1458 1465
41. P.S. Shepherd Identification of an important thyrotrophin binding site on the human thyrotrophin receptor using monoclonal antibodies Mol. Cell. Endocrinol. 149 1999 197 206
42. S. Costagliola Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors EMBO J. 21 2002 504 513
43. T. Ando A monoclonal thyroid-stimulating antibody J. Clin. Invest. 110 2002 1667 1674
44. J. Sanders Thyroid-stimulating monoclonal antibodies Thyroid 12 2002 1043 1050
45. S. Costagliola Generation of a mouse monoclonal TSH receptor antibody with stimulating activity Biochem. Biophys. Res. Commun. 299 2002 891 896
46. N.G. Morgenthaler Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity J. Clin. Endocrinol. Metab. 81 1996 3155 3161
47. J. Sanders Human monoclonal thyroid stimulating autoantibody Lancet 362 2003 126 128
48. S. Costagliola Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity Mol. Endocrinol. 18 2004 3020 3034
49. T. Ando Dissecting linear and conformational epitopes on the native thyrotropin receptor Endocrinology 145 2004 5185 5193
50. N.G. Morgenthaler Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum Mol. Cell. Endocrinol. 212 2003 73 79
51. F. Latrofa Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies J. Clin. Endocrinol. Metab. 89 2004 4734 4745
52. V. Michelangeli The prognostic value of thyrotropin receptor antibody measurement in the early stages of treatment of Graves' disease with antithyroid drugs Thyroid 8 1998 119 124
53. L. Wartofsky Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States Thyroid 1 1991 129 135
54. R.S. Bahn, and A.E. Heufelder Pathogenesis of Graves' ophthalmopathy N. Engl. J. Med. 329 1993 1468 1475
55. M. Zakarija, and J.M. McKenzie Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism J. Clin. Endocrinol. Metab. 57 1983 1036 1040
56. R.S. Brown Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies J. Clin. Endocrinol. Metab. 81 1996 1147 1151
57. T.F. Davies Thyroid controversy - stimulating antibodies J. Clin. Endocrinol. Metab. 83 1998 3777 3785
58. M. Zakarija, and J.M. McKenzie Effect of thyrotropin and of LATS on mouse thyroid cyclic AMP Metabolism 22 1973 1185 1191
59. P.F. Watson A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease Clin. Endocrinol. (Oxf.) 49 1998 577 581
60. C. Evans Development of a luminescent bioassay for thyroid stimulating antibodies J. Clin. Endocrinol. Metab. 84 1999 374 377
61. B.R. Smith, and R. Hall Thyroid-stimulating immunoglobulins in Graves' disease Lancet 2 1974 427 431
62. S. Costagliola Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease J. Clin. Endocrinol. Metab. 84 1999 90 97
63. M. Schott Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation Horm. Metab. Res. 32 2000 429 435
64. D. Maugendre, and C. Massart Clinical value of a new TSH binding inhibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay Clin. Endocrinol. (Oxf.) 54 2001 89 96
65. C. Massart Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs Clin. Chim. Acta 304 2001 39 47
66. I.B. Pedersen TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays Clin. Endocrinol. (Oxf.) 55 2001 381 390
67. L. Giovanella Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test Clin. Chem. Lab. Med. 39 2001 25 28
68. T. Zimmermann-Belsing Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease Eur. J. Endocrinol. 146 2002 173 177
69. M. Zakarija Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism J. Clin. Endocrinol. Metab. 62 1986 368 371
70. T. Inui Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay Thyroid 8 1998 319 325
71. D.H. Khoo Differences in the levels of TSH-binding inhibitor immunoglobulins in goitrous and agoitrous autoimmune thyroiditis after twelve months of l-thyroxine therapy Clin. Endocrinol. (Oxf.) 51 1999 73 79
72. N.G. Morgenthaler Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor Horm. Metab. Res. 30 1998 162 168
73. C. Lenzner, and N.G. Morgenthaler The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease Thyroid 13 2003 1153 1161
74. H. Schleusener Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease Acta Endocrinol. (Copenh.) 120 1989 689 701
75. U. Feldt-Rasmussen Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease J. Clin. Endocrinol. Metab. 78 1994 98 102
76. P. Vitti Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment Thyroid 7 1997 369 375
77. N. Takasu Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment Thyroid 10 2000 891 896
78. M. Schott Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease Horm. Metab. Res. 36 2004 92 96
79. R. Hoermann Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine Thyroid 12 2002 1119 1128
80. R. Nunez Miguel Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling Thyroid 14 2004 991 1011
81. Q.R. Fan, and W.A. Hendrickson Structure of human follicle-stimulating hormone in complex with its receptor Nature 433 2005 269 277